Mitochondrial dysfunction in anti-3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) immune-mediated necrotising myopathy.


Journal

Neuromuscular disorders : NMD
ISSN: 1873-2364
Titre abrégé: Neuromuscul Disord
Pays: England
ID NLM: 9111470

Informations de publication

Date de publication:
05 2022
Historique:
received: 21 01 2022
revised: 02 03 2022
accepted: 21 03 2022
pubmed: 30 4 2022
medline: 18 5 2022
entrez: 29 4 2022
Statut: ppublish

Résumé

Mitochondrial dysfunction is a plausible cause of muscle fibre damage in a number of myopathies including immune-mediated necrotising myopathy. However, histopathological evidence of mitochondrial dysfunction is not often described in immune-mediated necrotising myopathy and, when present, it is often attributed to patient age. The purpose of this study was to describe features of mitochondrial dysfunction on muscle biopsy in anti-3‑hydroxy-3-methylglutaryl-CoA reductase immune-mediated necrotising myopathy and explore whether these features are age-related. In this observational case control study, a statistically significant increase in the number of muscle fibres with increased lipid content (p = 0.004) and cytochrome c oxidase-negative/succinate dehydrogenase-positive fibres (p = 0.037) in anti-3‑hydroxy-3-methylglutaryl-coenzyme immune-mediated necrotising myopathy was found compared to age-matched controls. Therefore, histopathological features of mitochondrial dysfunction are more frequent in anti-3‑hydroxy-3-methylglutaryl-coenzyme immune-mediated necrotising myopathy than aged-matched controls and therefore, may be contributing to the pathogenesis.

Identifiants

pubmed: 35487868
pii: S0960-8966(22)00088-8
doi: 10.1016/j.nmd.2022.03.005
pii:
doi:

Substances chimiques

Autoantibodies 0
Coenzymes 0
Hydroxymethylglutaryl-CoA Reductase Inhibitors 0
HMGCR protein, human EC 1.1.1.-
Hydroxymethylglutaryl CoA Reductases EC 1.1.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

441-444

Informations de copyright

Crown Copyright © 2022. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ignacio Javier Acosta (IJ)

Neuropathology Department, John Radcliffe Hospital, Oxford University Hospitals Trust, Oxford, OX3 9DU, United Kingdom; Translational neurology and neurophysiology laboratory. Advance clinical research centre (CICA), School of Medicine, Universidad de Chile, Providencia, Santiago 7500787, Chile; Neurology and Psychiatry department, Clínica Alemana Santiago, Vitacura 5951, Vitacura, Santiago 7650568, Chile; Neurology and Neurosurgery department, Clínica Dávila, Recoleta, Santiago 8531657, Chile. Electronic address: iacosta@alemana.cl.

Monika Hofer (M)

Neuropathology Department, John Radcliffe Hospital, Oxford University Hospitals Trust, Oxford, OX3 9DU, United Kingdom.

Stefen Brady (S)

Oxford Muscle Service, Department of Neurology, John Radcliffe Hospital, Oxford University Hospitals Trust, Oxford OX3 9DU, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH